Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Element Biosciences raises $175 million in upsized Series E funding led by Samsung Electronics to enhance global growth in genomic solutions.
PRIVATEJun 09, 2026•2 months ago
Amount Raised
$175 Million
Round Type
Series E
San DiegoBiotechnologyHealth CareGeneticsLife Science
Investors
Samsung Electronics
Description
Element Biosciences, Inc. announced an upsized Series E round of financing with $175 million from Samsung Electronics. The funding will accelerate commercialization of genomic and multiomic solutions and expand its global presence. This capital will advance development of technologies like AVITI and VITARI
Company Information
Company
Element Biosciences
Location
San Diego, California, United States
About
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.
Related People
Suggested for you
1 contact
Verified contactsNo contacts on file at Element Biosciences yet.
Predictive Intelligence
Strategic
ML-powered predictions for Element Biosciences's next move
San DiegoBiotechnologyHealth CareGeneticsLife Science